ZynexのEPS Q / Q
ZynexのEPS Q / Qは何ですか。
Zynex, Inc.のEPS Q / Qは-13.33%です。
EPS Q / Qの定義は何ですか。
四半期EPS成長率(Quarterly EPS growth rate)は、過去4四半期の業績と比較して過去4四半期のEPSの増加です。
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
SZSEのセクタHealth CareにおけるEPS Q / Qの企業と比べるZynex
Zynexは何をしますか。
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Zynexと類似のeps q / q
- Progenics PharmaceuticalsのEPS Q / Qは-13.64%です。
- Plymouth Industrial Reit IncのEPS Q / Qは-13.64%です。
- Kimberly-ClarkのEPS Q / Qは-13.58%です。
- Simmons First NationalのEPS Q / Qは-13.51%です。
- LovesacのEPS Q / Qは-13.46%です。
- EquitableのEPS Q / Qは-13.37%です。
- ZynexのEPS Q / Qは-13.33%です。
- Kontoor Brands IncのEPS Q / Qは-13.28%です。
- Cohen & SteersのEPS Q / Qは-13.21%です。
- Mastech Digital IncのEPS Q / Qは-13.16%です。
- Avadel Pharmaceuticals plcのEPS Q / Qは-13.16%です。
- Enghouse SystemsのEPS Q / Qは-13.16%です。
- Pediatrix Medical IncのEPS Q / Qは-13.04%です。